Hyaluronic Acid Market Analysis, Size, Trends | Global | 2019-2025 | MedCore

  • Year: 2019
  • Scope: 2015-2025
  • Region: Australia, China, Europe, India, Japan, South Korea, United States
  • Pages: 2098
  • Published Date: 04/03/2019
  • Type: MedCore

Industry Trends

In the United States, hyaluronic acid (HA) viscosupplementation is approved only for osteoarthritis of the knee. However, many surgeons also use the injections off-label in indications such as ankle, shoulder and elbow. If market players were to acquire approval in other joints, it would greatly expand the hyaluronic acid market.

Continuous growth in unit sales drive this market, but there is considerable pricing pressure on these products in many regions.

Osteoarthritis, which is a condition marked by the degeneration of bone joints and cartilage, affected approximately 40 million people in the United States in 2016. Patients who suffer from osteoarthritis experience acute joint pain, tenderness, stiffness, creaking, locking of the joints and inflammation. These symptoms are caused by the degeneration of joint cartilage, subchondral bone and synovial fluid, specifically the polysaccharide hyaluronate.

Hyaluronic acid viscosupplementation has been available in the U.S. as a treatment for osteoarthritis since 1997. The injected hyaluronic acid is rapidly removed from the body, lasting no longer than a week. The injection results in physiological changes that lead to a variety of outcomes, such as endogenous hyaluronic acid production, reduced inflammation response due to effects on cytokines, reduced cartilage and cell degradation, etc. Hyaluronic acid injection also allows for long-term improvements in mobility and range of motion, and prevents further joint and cartilage deterioration.

Overall, the European HA market is stable in terms of market value growth. This has been caused by lower ASPs across many European countries in recent years, due to healthcare budget constraints that have led to lower reimbursement rates. This is especially evident in the five-injection market in Germany.

Across other Asia-Pacific regions, the trends vary dramatically. South Korea is seeing recovery since market declines around 2014, and India is seeing its small market grow rapidly, largely due to Single-Injection, a stark contrast to China’s growth in primarily the Five-Injection market.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:

  • United States
  • Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
  • China
  • India
  • Japan
  • South Korea
  • Australia

Highly Detailed Segmentation

  • Five-Injection Hyaluronic Acid Viscosupplementation Market
  • Three-Injection Hyaluronic Acid Viscosupplementation Market
  • Two-Injection Hyaluronic Acid Viscosupplementation Market
  • Single-Injection Hyaluronic Acid Viscosupplementation Market

hyaluronic acid viscosupplementation market research segmentation map for latest report by iData Research

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Hyaluronic Acid Market Share Insights

This market is highly fragmented across different regions. DePuy Synthes, for example, is the market leader in the United States, however, does not have a position in the European market for hyaluronic acid. Instead Fidia Farmaceutici S.p.A. dominates the European market, with nearly one-third of the market share, particularly due to their strong position in their home country, Italy. Fidia’s well-established and reputable products, Hyalubrix® and Hyalgan®, maintained a strong presence in these regions.

The single-injection MONOVISC® and the three-injection ORTHOVISC® are marketed and distributed by DePuy Synthes through a partnership agreement with the manufacturer, Anika Therapeutics, which simply collects royalties. MONOVISC® and ORTHOVISC® have remained the leaders in the combined single- and multi-injection segments throughout 2018 and revenue has continued to increase domestically.

Throughout this entire market study, iData’s team of analysts research over 50 companies. The full list of companies can be seen below:

All Companies Analyzed in this Study

  • Ajanta Pharma
  • Aju Pharm
  • Alkem Laboratories
  • Anika
  • Bharat Biotech
  • Bioiberica
  • Bioventus
  • Bloomage Freda Biopharm
  • Cadila Pharmaceutical
  • Chugai Pharma
  • Croma-Pharma
  • Curasan
  • DePuy Synthes
  • Doctor Reddy’s Laboratory
  • Documedica
  • Dong Kwang
  • DongKook
  • Ferring Pharmaceuticals
  • Fidia Pharamaceuticals
  • FocusChem Biotech Limited
  • Genzyme
  • Gland Pharma
  • Hanghzhou Gallop Biological Products
  • Hanmi Pharm
  • Harbin Gloria Pharmaceutical
  • Intas Pharmaceuticals
  • Kinedex Healthcare
  • Kunming Baker Norton
  • Laboratoire Genevrier
  • LCA Pharma
  • LG Life Science
  • Maruho
  • Meda Pharma
  • Meiji Seika Pharma
  • OrthogenRx
  • Pacific Pharma
  • Plasmaconcept AG
  • Ranbaxy
  • Recordati
  • Saehan Pharma
  • Sanofi
  • Seikagaku
  • Shanghai HaoHai
  • Shanghai Jingfeng Pharmaceutical
  • Shin Poong
  • Stella Pharmaceuticals
  • Sun Pharma Laboratories
  • Taisho
  • Tedec-Meiji
  • TRB Chemedica
  • Unimed
  • Virchow Biotech
  • Zimmer Biomet
  • Zydus Cadila

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Orthobiologics Market Analysis – MedSuite

FREE Sample Report

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology